Rfx6 directs islet formation and insulin production in mice and humans.
Insulin from the beta-cells of the pancreatic islets of Langerhans controls energy homeostasis in vertebrates, and its deficiency causes diabetes mellitus. During embryonic development, the transcription factor neurogenin 3 (Neurog3) initiates the differentiation of the beta-cells and other islet cell types from pancreatic endoderm, but the genetic program that subsequently completes this differentiation remains incompletely understood. Here we show that the transcription factor Rfx6 directs islet cell differentiation downstream of Neurog3. Mice lacking Rfx6 failed to generate any of the normal islet cell types except for pancreatic-polypeptide-producing cells. In human infants with a similar autosomal recessive syndrome of neonatal diabetes, genetic mapping and subsequent sequencing identified mutations in the human RFX6 gene. These studies demonstrate a unique position for Rfx6 in the hierarchy of factors that coordinate pancreatic islet development in both mice and humans. Rfx6 could prove useful in efforts to generate beta-cells for patients with diabetes.
Diabetes Center, University of California San Francisco, San Francisco, California 94143, USA.
Stuart B
SB
Smith
Hui-Qi
HQ
Qu
Nadine
N
Taleb
Nina Y
NY
Kishimoto
David W
DW
Scheel
Yang
Y
Lu
Ann-Marie
AM
Patch
Rosemary
R
Grabs
Juehu
J
Wang
Francis C
FC
Lynn
Takeshi
T
Miyatsuka
John
J
Mitchell
Rina
R
Seerke
Julie
J
Désir
Serge
S
Vanden Eijnden
Marc
M
Abramowicz
Nadine
N
Kacet
Jacques
J
Weill
Marie-Eve
ME
Renard
Mattia
M
Gentile
Inger
I
Hansen
Ken
K
Dewar
Andrew T
AT
Hattersley
Rennian
R
Wang
Maria E
ME
Wilson
Jeffrey D
JD
Johnson
Constantin
C
Polychronakos
Michael S
MS
German
D000818:Animals; D051792:Basic Helix-Loop-Helix Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D002454:Cell Differentiation; D004252:DNA Mutational Analysis; D004268:DNA-Binding Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000151:congenital / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D004622:Embryo, Mammalian / Q000378:metabolism; D005260:Female; D005333:Fetus / Q000378:metabolism; D020869:Gene Expression Profiling; D018507:Gene Expression Regulation, Developmental; D005808:Genes, Recessive / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D007231:Infant, Newborn; D007328:Insulin / Q000096:biosynthesis*; D007515:Islets of Langerhans / Q000166:cytology* / Q000196:embryology / Q000378:metabolism*; D008297:Male; D051379:Mice; D041681:NIH 3T3 Cells; D009419:Nerve Tissue Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D009928:Organ Specificity; D000071701:Regulatory Factor X Transcription Factors; D013577:Syndrome; D014157:Transcription Factors / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*
D051792:Basic Helix-Loop-Helix Proteins; D004268:DNA-Binding Proteins; D007328:Insulin; D009419:Nerve Tissue Proteins; D000071701:Regulatory Factor X Transcription Factors; D014157:Transcription Factors; C407737:Neurog3 protein, mouse; C547964:Rfx6 protein, human; C547963:Rfx6 protein, mouse